137 related articles for article (PubMed ID: 28425416)
21. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
O'Toole R; Romeril K; Bromhead C
Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
[TBL] [Abstract][Full Text] [Related]
22. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
[TBL] [Abstract][Full Text] [Related]
23. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study.
Milet J; Le Gac G; Scotet V; Gourlaouen I; Thèze C; Mosser J; Bourgain C; Deugnier Y; Férec C
Blood Cells Mol Dis; 2010 Jan; 44(1):34-7. PubMed ID: 19879168
[TBL] [Abstract][Full Text] [Related]
24. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
25. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
26. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
27.
Pelucchi S; Ravasi G; Arosio C; Mauri M; Piazza R; Mariani R; Piperno A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513852
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a screening program for iron overload and HFE mutations in 50,493 blood donors.
Eckerström C; Frändberg S; Lyxe L; Pardi C; Konar J
Ann Hematol; 2020 Oct; 99(10):2295-2301. PubMed ID: 32844323
[TBL] [Abstract][Full Text] [Related]
29. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
[TBL] [Abstract][Full Text] [Related]
30. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
Press RD; Flora K; Gross C; Rabkin JM; Corless CL
Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
[TBL] [Abstract][Full Text] [Related]
31. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.
Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685
[TBL] [Abstract][Full Text] [Related]
32. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
33. HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping.
Koefoed P; Dalhoff K; Dissing J; Kramer I; Milman N; Pedersen P; Simonsen K; Tygstrup N; Nielsen FC
Scand J Clin Lab Invest; 2002; 62(7):527-35. PubMed ID: 12512743
[TBL] [Abstract][Full Text] [Related]
34. The Study of HFE Genotypes and Its Expression Effect on Iron Status of Iranian Haemochromatosis, Iron Deficiency Anemia Patients, Iron-Taker and Non Iron-Taker Controls.
Beiranvand E; Abediankenari S; Rostamian M; Beiranvand B; Naazeri S
Recent Adv DNA Gene Seq; 2015; 9(1):58-64. PubMed ID: 25687342
[TBL] [Abstract][Full Text] [Related]
35. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
36. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
37. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
38. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
39. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
40. HFE mutations, iron deficiency and overload in 10,500 blood donors.
Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
